INTRODUCTION {#S1}
============

Alcohol consumption is a common, complex trait, and heavy alcohol use increases the risk of alcohol use disorders (abuse and dependence).^[@R1]--[@R3]^ Drinking above the NIAAA-recommended maximum safe limits of no more than 14 drinks per week for men and 7 drinks per week for women is associated with an increased risk of alcohol-related harm.^[@R4]--[@R6]^ The harms from excessive alcohol consumption include a greater risk of a number of health conditions, including liver, cardiovascular, and infectious diseases, cancer, and neuropsychiatric disorders.^[@R7]--[@R16]^ Excessive alcohol consumption is also a preventable risk factor for many injuries and accidents.^[@R15]--[@R17]^ In total, excessive alcohol consumption contributes to nearly 3.3 million deaths per year worldwide (or 5.9% of all deaths), and 9.8% of all deaths in the United States.^[@R16],\ [@R18],\ [@R19]^

Alcohol drinking behavior can be measured in a number of ways, including cross-sectional measures of alcohol consumption (e.g. drinks per week), and lifetime measures (e.g. alcohol dependence). There is strong evidence that individual variation in each of these measures is determined by both genetic and environmental factors, and there is strong, if incomplete genetic correlation among them.^[@R20],\ [@R21]^ Genetic epidemiologic studies, such as twin and family/adoption studies, have estimated that about half of the variance in these traits may be explained by genetic factors.^[@R20],\ [@R22],\ [@R23]^ Genetic association studies have demonstrated a pharmacogenetic effect of missense variants in genes in the alcohol metabolism pathway, specifically, alcohol dehydrogenase 1B (*ADH1B*) and aldehyde dehydrogenase 2 (*ALDH2)*, that influence lifetime measures, such as risk of alcohol dependence.^[@R24],\ [@R25]^ While these variants play an important role in determining individual levels of alcohol use, they explain a small proportion of the genetic contribution to variation in alcohol use reported in twin studies. Recently, genome-wide association studies (GWAS) of alcohol consumption have identified potential novel susceptibility loci, however, only a few have been confirmed in independent samples.^[@R26]--[@R29]^ That suggests that there remain specific genetic factors that could be discovered in large and ethnically diverse populations, using genotyping platforms with improved genome-wide coverage.

To address this gap, we conducted a GWAS of alcohol consumption in the large and ethnically diverse Genetic Epidemiology Research in Adult Health and Aging (GERA) cohort (n=110 266). It has been previously noted that the use of questionnaire data in large cohorts such as ours may be an efficient and productive approach towards elucidating the genetic basis of alcohol-related traits.^[@R30]^ We examined two statistically independent phenotypes reflecting subjects' alcohol consumption during the past year, based on self-reported information: any intake (drinker/non-drinker status) and the regular quantity of drinks consumed per week (drinks/week), in four race/ethnicity groups (non-Hispanic whites, Hispanic/Latinos, East Asians, and African Americans) analyzed individually and also combined in a trans-ethnic meta-analysis. Further, we assessed genetic variants that had previously been reported to be associated with alcohol consumption and related traits in our cohort.

MATERIALS AND METHODS {#S2}
=====================

Study Population {#S3}
----------------

We analyzed participants from the Genetic Epidemiology Research in Adult Health and Aging (GERA) cohort which includes 110 266 adult men and women members of the Kaiser Permanente Medical Care Plan, Northern California Region (KPNC) and has been described in detail (dbGAP at <http://ncbi.nlm.nih.gov/gap> (Study Accession: phs000674.v2.p2)).^[@R31],\ [@R32]^ In this study, we focused on subjects who were at least 21 years of age at time of the survey, were of non-Hispanic white, Hispanic/Latino, Asian, or African American race/ethnicity, and provided self-reported information regarding their alcohol consumption during the past year (N=86 627) ([Table 1](#T1){ref-type="table"}). All study procedures were approved by the Institutional Review Board of the Kaiser Foundation Research Institute.

Phenotype Definitions {#S4}
---------------------

Two statistically independent alcohol consumption phenotypes were examined: any intake (drinker/non-drinker status) and the regular quantity of alcoholic drinks consumed per week as a quantitative trait (drinks/week). Both phenotypes were assessed based on the Research Program on Genes, Environment, and Health (RPGEH) survey. On this survey, participants were asked regarding the past year: "On average, how many days a week do you have a drink containing alcohol?" (no days, 1 day, 2 days, 3 days, 4 days, 5 days, 6 days, or every day). Further, participants were asked: "On a typical day that you drink, how many drinks do you have?" (none, 1, 2, 3, 4, 5, 6, 7, or ≥8). Individuals who reported drinking ≥ 1 day per week and ≥ 1 drink per day were defined as 'drinkers', whereas those who provided negative answers ("no days" and "none") were considered as 'non-drinkers'. For alcohol drinkers, the regular quantity of alcohol drinks consumed per week was calculated by multiplying the two answers. Because this quantitative measure of quantity of alcoholic drinks consumed per week was positively skewed, we performed a log transformation prior to conducting genetic association analyses.

Genotyping and Quality Control Procedures {#S5}
-----------------------------------------

DNA samples were extracted from Oragene kits (DNA Genotek Inc., Ottawa, ON, Canada) at KPNC and genotyped at the Genomics Core Facility of the Institute for Human Genetics at the University of California, San Francisco (UCSF) on four race/ethnicity-specific Affymetrix Axiom arrays (Affymetrix, Santa Clara, CA, USA) optimized for individuals of European, African American, East Asian, and Latino race/ethnicity.^[@R32]^ Design details and genome-wide coverage of those arrays have been previously described.^[@R33],\ [@R34]^ Genotype quality control (QC) procedures for the GERA cohort were performed on an array-wise basis as described in detail elsewhere.^[@R32]^ Briefly, we included SNPs with initial genotyping call rate ≥ 97%, allele frequency difference (≤ 0.15) between males and females for autosomal markers, and genotype concordance rate (\> 0.75) across duplicate samples. Around 94% of samples and more than 98% of genetic markers assayed passed QC procedures.^[@R32]^ Prior to imputation, we additionally excluded genetic markers with a minor allele frequency (MAF) \< 1%, or a genotype call rate \< 90%.

Imputation {#S6}
----------

Imputation was also conducted on an array-wise basis and has been described elsewhere.^[@R35]^ Following the pre-phase of the genotypes with Shape-IT v2.5,^[@R36]^ genetic markers were imputed from the cosmopolitan reference panel of the 1000 Genomes Project (phase I integrated release) using IMPUTE2 v2.3.1.^[@R37]--[@R39]^ As a QC metric, we used the info *r^2^* from IMPUTE2, which estimates the correlation between the true and imputed genotype.^[@R40]^ Herein, we reported imputed markers with info-metric *r^2^* ≥ 0.9 and MAF ≥ 1%; all reported genotyped markers exceeded a genotype call rate ≥ 98%, and a p-value ≥ 0.001 for Hardy-Weinberg equilibrium deviation.

Single Nucleotide Polymorphisms (SNPs) Selection for Extending Prior GWAS Findings {#S7}
----------------------------------------------------------------------------------

SNPs previously reported to be associated at the genome-wide level of significance (p\<5×10^−8^) with alcohol consumption-related traits, including the maximum quantity of drinks consumed in a 24 hour period (MaxDrinks), were examined for association in this sample. When several SNPs were reported at a genome-wide level of significance at the same locus/gene, we chose the SNP with the most significant p-value. In total, 14 SNPs other than our top GWA findings were selected ([Supplementary Table 1](#SD1){ref-type="supplementary-material"}), including 7 SNPs previously associated in European ancestry populations,^[@R26]--[@R29]^ 4 SNPs in Asian ancestry populations,^[@R41]--[@R43]^ and 3 SNPs in African ancestry populations.^[@R26]^ As two candidate SNPs (rs2309169 and rs200475889) were not in 1000 Genomes Project (phase I) and so could not be imputed, 12 SNPs remained for association analysis.

Statistical Analysis {#S8}
--------------------

### GWAS Analyses and Covariate Adjusment {#S9}

GWA analyses were conducted using PLINK^[@R44]^ v1.07 (<http://pngu.mgh.harvard.edu/purcell/plink/>) and R^[@R45]^ (<https://www.R-project.org>). Regional Manhattan plots were performed using LocusZoom v1.1 (<http://locuszoom.sph.umich.edu/locuszoom/>) including SNP association values ± 1Mb upstream and downstream of our peak significant SNPs.^[@R46]^ We assessed single-marker associations with drinker status and with the quantity of alcoholic drinks consumed per week using logistic and linear regression, respectively. We assumed an additive genetic model using allele counts (i.e., 0, 1, or 2 copies of the minor allele) for typed markers or additive dosages for imputed markers. We first analyzed each of the four race/ethnicity groups separately, adjusting for age, and sex, and lean body mass, which serves as a proxy for body size.^[@R47]^ Lean body mass was estimated using the James equation which relies on sex, height (cm), and total body weight (kg).^[@R48]^ We conducted sensitivity analyses without lean body mass as a covariate, and those analyses without lean body mass produced relatively similar results ([Supplementary Table 2](#SD1){ref-type="supplementary-material"}). To correct for differences in genetic ancestry, we include ancestry principal components (PCs) in our GWA analyses. To calculate the PCs, we used Eigenstrat^[@R49]^ v4.2 on each of the four race/ethnicity groups as previously described.^[@R31]^ For the non-Hispanic Whites, the first 10 ancestry PCs were included in each regression model, while for the 3 other race/ethnicity groups, the first 6 ancestry PCs were included. For the non-Hispanic whites, the percentage of Ashkenazi ancestry was also used as a covariate in the GWA analyses to adjust for genetic ancestry, as described previously.^[@R31]^ Further, the genomic inflation factor λ was calculated for each GWA analysis to assess inflation due to population stratification and was found to be modest (all ≤ 1.07).

### Trans-Ethnic Meta-Analysis {#S10}

For the combined meta-analysis of the two alcohol consumption phenotypes across the 4 race/ethnicity groups, fixed effects and random effects summary estimates were calculated for an additive model using R package "meta". Heterogeneity index, *I^2^* (0--100%) as well as *P*-value for Cochrane's Q statistic were assessed among groups. We report fixed effects results, except when there was significant heterogeneity between race/ethnicity groups, in which case we report values for a random effects model.

### Association Analysis of Previously Reported SNPs {#S11}

To determine whether the 12 SNPs previously-reported as genome-wide significant in GWAS for alcohol consumption-related traits (e.g. MaxDrinks) were associated with alcohol consumption in the current study, we used a nominal significance level of 0.05. A more stringent multiple testing correction accounting for the 2 phenotypes tested and for the number of variants tested for each ethnic group is also presented (Bonferroni-corrected alpha level of 0.05/(2×6) for European population, of 0.05/(2×4) for Asian population, and of 0.05/(2×2) for African ancestry population).

### Conditional Analysis {#S12}

To assess whether the *GCKR*, and *KLB* SNPs recently reported by Schumann et *al.*,^[@R29]^ contribute to alcohol consumption independently from our most strongly associated SNPs in our trans-ethnic meta-analysis, we adjusted for the effect of our top SNPs (rs4665985, and rs7686419) in our non-Hispanic white sample. In addition, to assess whether previously reported SNPs in the *CCDC63*, *MYL2*, *C12orf51*, and *OAS3* genes in the chromosome 12q24 region, that also reached genome-wide significance in our sample, contribute independently from the *ALDH2* locus to alcohol consumption in East Asians, we reran association analysis by including rs671 (our top SNP) as a covariate in the regression model.

RESULTS {#S13}
=======

Study Population {#S14}
----------------

In this study, the proportion of subjects that report consuming alcohol (drinkers) was greatest for non-Hispanic whites (67.5 %) followed by Hispanic/Latinos (62.1%), African Americans (52.9%), and East Asians (45.5%) ([Table 1](#T1){ref-type="table"}). Among drinkers, the average number of alcoholic drinks consumed per week during the past year followed a similar pattern, with 7.3 for non-Hispanic whites, 6.1 for Hispanic/Latinos, 5.6 for African Americans, and 4.9 for East Asians. We also observed a lower proportion of drinkers and reduced number of drinks per week in women compared to men in all race/ethnicity groups ([Supplementary Figures 1 -- 2](#SD1){ref-type="supplementary-material"}).

Top GWAS Findings {#S15}
-----------------

We first conducted a GWAS analysis of the two alcohol consumption phenotypes, stratified by race/ethnicity, detecting two loci associated at a genome-wide level of significance (p\<5×10^−8^). The strongest association was observed in East Asians between the well-known *ALDH2* locus^[@R25]^ on 12q24 and alcohol drinker status ([Figure 1](#F1){ref-type="fig"}. a). This association was driven by the missense SNP rs671 in *ALDH2* (G\>A Glu457Lys), with subjects carrying the rs671 A allele considerably less likely to report any alcohol intake (OR=0.40, p=2.28×10^−72^) ([Table 2](#T2){ref-type="table"}). Among East Asian subjects who report drinking alcohol, we also observed an association between rs671 and a reduction of 0.76 drinks/week per copy (p=5.42×10^−4^). rs671 was not polymorphic (MAF\<0.5%) in non-Hispanic whites and African Americans, and was observed at a low frequency with poor imputation quality in Hispanic/Latinos, and so was excluded from the analysis in these race/ethnicity groups. The second strongest association was detected in non-Hispanic white subjects for the well-known rs1229984^[@R25]^, a missense SNP in *ADH1B* (C\>T Arg48His), which was associated with both alcohol consumption phenotypes. Subjects who carry the rs1229984 T allele were less likely to report consuming alcohol (OR=0.79, p=2.47×10^−20^), and among those who did report consuming alcohol, a reduction of 1.26 drinks per week per copy was reported (p=1.91×10^−35^). Similarly, we found associations between *ADH1B* rs1229984 and both alcohol consumption phenotypes in Hispanic/Latinos (OR=0.72, p=4.35×10^−7^ and β=−0.21, p=2.58×10^−6^). *ADH1B* rs1229984 showed a consistent direction of effect in all race/ethnicity groups, however, the effect of this SNP in East Asians was smaller than in the other groups. To determine whether the effect of *ADH1B* rs1229984 was attenuated by the strong effect of *ALDH2* rs671 in East Asians, we performed a sub-group analysis among those not carrying the protective allele at *ALDH2* rs671 (GG homozygotes). For drinker/non-drinker status, we found similar results (OR=0.94, p=0.21) than in the non-stratified East Asian sample. However, for the quantitative trait drinks/week, we found a relatively small effect of rs1229984 in this sub-group analysis (β=−0.04, p=0.19), suggesting that the effect of *AHD1B* rs1229984 on alcohol consumption in East Asians may not be as important as in other race/ethnicity groups.

Trans-Ethnic Meta-Analysis {#S16}
--------------------------

We then conducted a combined meta-analysis across the 4 race/ethnicity groups (non-Hispanic Whites, Hispanic/Latinos, East Asians, and African Americans) for the two alcohol consumption phenotypes. We identified two loci that exceeded genome-wide significance (p\<5.0×10^−8^) with drinks/week in the regions of *GCKR* (rs4665985, beta=0.04, p=2.26×10^−8^), and *KLB* (rs7686419, beta=−0.04, p=3.41×10^−10^) ([Table 2](#T2){ref-type="table"}). Consistently, *GCKR* rs4665985 and *KLB* rs7686419 were also associated with drinker status (p=5.0×10^−4^ and 4.08×10^−5^, respectively). Regional Manhattan plots on chromosome 2 and 4 near *GCKR* and *KLB*, respectively, are shown in [Figure 2](#F2){ref-type="fig"}. Results for each individual race/ethnicity group are also presented in [Table 2](#T2){ref-type="table"}, showing no evidence of heterogeneity.

Extending Findings from Prior GWAS {#S17}
----------------------------------

Finally, we investigated a total of 12 SNPs (6 SNPs for European ancestry subjects, 4 SNPs for East Asian ancestry subjects, and 2 SNPs for African ancestry subjects) associated with alcohol consumption-related traits (e.g. MaxDrinks) at a genome-wide significance level in previous studies ([Supplementary Table 1](#SD1){ref-type="supplementary-material"}).^[@R26]--[@R29],\ [@R41]--[@R43]^ In non-Hispanic whites, the strongest evidence of association was obtained for *GCKR* rs780094 and *KLB* rs11940694 (the same two loci identified in our meta-analysis) with drinks/week (beta=−0.034, Bonferroni-corrected p=2.86 × 10^−6^ and beta=−0.035, p=1.64 × 10^−6^, respectively) ([Table 3](#T3){ref-type="table"}). The same two SNPs were also associated with drinker status in a consistent direction (OR=0.96, Bonferroni-corrected p=0.013 and OR=0.95, p=0.002, respectively). These findings are consistent with the recent report from Schumann *et al.*, who observed genome-wide significant associations for these two SNPs, in their discovery GWAS and in their combined discovery and replication data of European descent, respectively.^[@R29]^ However, when we repeated the analyses, conditioning on our most strongly associated SNPs from our trans-ethnic meta-analysis (rs4665985 at *GCKR* and rs7686419 at *KLB*), *GCKR* rs780094 and *KLB* rs11940694 did not remain significant (p=0.10 and 0.38, respectively), suggesting that our top associated SNPs and theirs represent the same signals at those two loci. We also confirmed the association between *AUTS2* rs6943555 and drinks/week (beta=0.03, Bonferroni-corrected p=0.005) and a consistent but not significant association with drinker status. This SNP was previously associated with MaxDrinks in a meta-analysis combining 26,316 European-ancestry individuals.^[@R27]^ In non-Hispanic whites, we further detected weak suggestive associations of drinks/week (but not drinker status) with rs1799876 in *SERPINC1* and drinker status (but not drinks/week) with rs11128951 at the *SGOL1* locus, both of which were previously associated with MaxDrinks.^[@R26],\ [@R28]^ In East Asians, we observed genome-wide significant associations with alcohol drinker status for the 4 SNPs tested in the region of 12q24. None of these association signals remained significant, however, after conditioning on rs671 (our most strongly associated SNP), indicating that these SNPs do not contribute independently to variation in alcohol consumption in East Asians ([Figure 1](#F1){ref-type="fig"}. b). In African Americans, the *LOC100507053/ADH1B* loci with SNPs rs28864441 and rs2066702 previously associated with MaxDrinks^[@R26]^, showed marginal evidence of association with drinks/week (but not drinker status) in our sample ([Table 3](#T3){ref-type="table"}). However, we note that the African Americans are the smallest subgroup in our study. Taken together, 3 of the 12 SNPs tested (25.0%) remained significant after Bonferroni correction and conditioning on the most significant SNP in each region. Thus, we confirmed and extended previous findings implicating *AUTS2*, *SGOL1*, and *SERPINC1* genes in alcohol consumption-related traits in non-Hispanic whites.

DISCUSSION {#S18}
==========

In this study we observed substantial differences in alcohol drinking behavior across race/ethnicity groups, particularly in East Asians who have a larger proportion of non-drinkers than other groups, and fewer drinks per week among those who do drink. This appears to be driven by *ALDH2* rs671, which is the strongest effect SNP in our GWAS analyses and seen almost exclusively in the East Asian group. Our findings are consistent with previous genetic association studies which have reported strong evidence for association with alcohol consumption-related traits in the region of 12q24 in Asian populations, most likely due to linkage disequilibrium with *ALDH2* rs671.^[@R41]--[@R43],\ [@R50]^ Our results support that rs671 is a single hit with no other independently associated risk variants nearby, as our conditional analysis completely attenuated the result for previously reported SNPs at 12q24. Our second strongest SNP association, between *ADH1B* rs1229984 and alcohol consumption in non-Hispanic whites, is consistent with previous findings in European Americans.^[@R26],\ [@R51]^ However, *ADH1B* rs1229984 had a relatively smaller effect in our East Asian sample in comparison to other race/ethnicity groups, suggesting that its effect might be attenuated by *ALDH2* rs671 in East Asians. Previous studies have found that both genetic polymorphisms *ADH1B* rs1229984 and *ALDH2* rs671 are especially common in Asian populations,^[@R52],\ [@R53]^ and that they significantly influence drinking behavior in a synergistic manner.^[@R54]^ To determine whether the relatively small effect of rs1229984 in East Asians was due to the strong effect of *ALDH2* rs671, we examined the association of *ADH1B* rs1229984 among those East Asians who do not carry the non-drinking allele of rs671. The association for rs1229984 was not increased in this sub-group analysis, suggesting that the effect of *AHD1B* rs1229984 on alcohol consumption in East Asians may not be as important as in other race/ethnicity groups.

*ADH1B* and *ALDH2* play a central role in the metabolism of alcohol in humans, and the functional impact of their two missense polymorphisms rs1229984 and rs671 has been extensively reviewed elsewhere.^[@R24],\ [@R25]^ *In vivo*, individuals who carry at least one copy of rs1229984 eliminate ethanol more quickly after heavy drinking and have lower blood alcohol concentrations in comparison to homozygous wild-type individuals.^[@R55],\ [@R56]^ Thus, individuals who carry at least one copy of rs1229984 are less exposed to circulating ethanol and might be less likely to develop a tolerance and dependence to alcohol, as previously speculated.^[@R55],\ [@R56]^ Our findings provide additional strong evidence of *ADH1B* rs1229984 as the variant in the *ADH* gene cluster with the largest impact on alcohol consumption, as previously reported.^[@R57],\ [@R58]^ On the other hand, rs671 impairs the processing of ALDH2, causing an accumulation in the body of acetaldehyde, which is toxic and leads to undesirable reactions, including nausea.^[@R56],\ [@R59]^ Early work demonstrated the strong effect of a single non-functional allele at this locus, as heterozygotes and homozygotes for rs671 (GA and AA genotypes) are deficient in ALDH2 activity, suggesting that rs671 allele A is dominant.^[@R60]^ Therefore, individuals who carry at least one copy of rs671 drink typically less, and are protected against heavy alcohol use and alcohol use disorders.^[@R50],\ [@R61]^ Consistently, we found that GERA subjects who carried even a single deficient metabolizing allele of *ALDH2* rs671 were less likely to consume alcohol. Thus, the current study adds further evidence of an effect on average alcohol drinking of *ADH1B* and *ALDH2*, whereas much of the extensive prior literature is on effects on lifetime measures, such as risk of alcohol dependence.^[@R25],\ [@R61]--[@R64]^

In this study, we also identified two loci for alcohol consumption in our trans-ethnic meta-analysis. One of these loci was near *KLB* on chromosome 4 and showed the strongest association with alcohol consumption in our meta-analysis. The second locus with genome-wide significance was near *GCKR* on chromosome 2. Our findings are consistent with a recent study reporting genome-wide associations at those two loci with daily alcohol intake (log grams per day) in a large meta-analysis of Europeans,^[@R29]^ even though the strongest SNPs reported by Schumann *et al.* were different than ours. However, our lead SNPs at *KLB* and *GCKR* loci were relatively close to theirs (8.6 and 12.6 kb apart) and were moderately correlated in European ancestry populations (*r*^2^ ranged from 0.4 to 0.6). Our conditional analyses also indicated that our lead SNPs and theirs represent the same signals at those two loci, suggesting that all the identified SNPs (rs780094 and rs4665985 at *GCKR*, and rs11940694 and rs7686419 at *KLB*) are most likely proxies of causal variants influencing alcohol consumption.

Our results also extend findings of previous studies implicating other genes in determining variation in alcohol consumption and related phenotypes (e.g. MaxDrinks), especially in European-ancestry populations, including *AUTS2*, *SGOL1*, and *SERPINC1*. Schumann *et al.* previously reported a genome-wide association with alcohol consumption for *AUTS2* rs6943555 in a meta-analysis combining 26,316 European-ancestry individuals.^[@R27]^ Two other studies conducted in European-ancestry populations identified potential novel loci associated with MaxDrinks, including *SGOL1* rs11128951,^[@R28]^ and *SERPINC1* rs1799876.^[@R26]^ We obtained modestly consistent results for these loci with alcohol consumption during the past year in our independent non-Hispanic white sample.

In contrast, other SNPs that were reported as genome-wide significant in previous GWAS of MaxDrinks, were not associated with either of our alcohol consumption traits in the current study. Specifically, several SNPs in *DDC* at 7p12.2 showed significant associations with MaxDrinks in a previous study in a European ancestry population,^[@R28]^ however *DDC* rs11575537 was not associated in our European ancestry sample with either of our traits. This lack of association at *DDC* is consistent with prior results of Xu *et al*. where no significant association with MaxDrinks was observed at this locus.^[@R26]^ In addition, two genome-wide associations for MaxDrinks previously reported in African Americans for *ADH1B* rs2066702, and rs28864441 at *LOC100507053*,^[@R26]^ were not associated with alcohol consumption in our African ancestry sample. However, we note that the African American subgroup is the smallest in our study, and we may have been underpowered to detect effects with statistical significance.

Finally, lack of an association may be influenced by variation in genotyping array coverage, because coverage affects the power to detect individual variants.^[@R65]--[@R67]^ Differences in coverage may explain why previous studies did not report a significant association between alcohol consumption-related traits and *ALDH2* rs671 in Asian populations or *ADH1B* rs1229984 in European ancestry populations.

We recognize several potential limitations of our study. First, the alcohol consumption phenotypes were based on self-reported information, which may result in underestimates of the effects of individual SNPs due to phenotype misclassification. Nonetheless, self-reported measures of alcohol consumption, including drink frequency and regular quantity at the time of heaviest drinking, have been shown to correlate strongly with the genetic risk for alcohol use disorders such as dependence.^[@R20]^ Second, the GERA cohort members are older on average than the general population, which could affect both the generalizability of our findings and our power to observe genetic effects which may be strongest in young adulthood. For instance, older subjects may consume alcohol in a different manner (e.g. better quality of alcoholic beverages, low-risk pattern of drinking while eating) in comparison to younger subjects.^[@R16]^ Further, older subjects may reduce their alcohol consumption due to comorbid conditions or medication use. In addition, participants included in the present study may be healthier and/or more affluent than the general population, as they are all members of the KPNC health plan. We recognize that our restriction to study common variants (MAF ≥ 1%) cannot exclude the possibility that rare functional variants may contribute to variation in alcohol consumption. Despite these limitations, our study is based on a unique and very large cohort of individuals, who were all members of a single integrated delivery system. Participants were recruited in a similar manner, and were assessed for their alcohol consumption using a single questionnaire providing more consistency, in contrast to consortia which often include different questions across studies. Samples were genotyped on a single platform, overall allowing us to confirm previous associations with the most established alcohol consumption-related risk variants in terms of effect size and direction.

It is also important to note phenotypic differences between this study and previous ones. Most previous GWAS studies have focused on lifetime measures related to alcohol use, such as alcohol dependence, while others have used a single time measure of maximum drinks in a 24-hour period. By comparison, ours focused on two measures of alcohol consumption over the past year (drinker status and drinks/week). All of these traits have been shown to be highly correlated genetically, but there are also differences. For example, alcohol use disorders (abuse or dependence) are reflective of lifetime exposure -- but also other potential factors not directly related to consumption. That could explain why some genetic findings associated with alcohol use disorders might not be found associated with measures of alcohol consumption. However, our findings have generally confirmed prior associations, suggesting that many of the previously reported genetic variants for alcohol use disorders are directly related to consumption, measured either over a short or long time period.

In conclusion, we identified 4 loci associated with alcohol consumption at a genome-wide significance level, including *ALDH2*, *ADH1B*, *KLB*, and *GCKR*. Our results also extend previous findings implicating *AUTS2*, *SGOL1*, and *SERPINC1* genes in alcohol consumption-related traits in non-Hispanic whites. Our study of 86 627 individuals had 80% power to detect effects of common SNPs (MAF\>0.10) of 1.10 on drinker status and a proportion of variance of 0.05% in drinks/week. This suggests that future genetic association studies of alcohol consumption traits will need to include hundreds of thousands if not millions of subjects to identify and confirm the small effects of individual SNPs on these phenotypes.
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======================

The study was supported by the National Institute of Alcohol Abuse and Alcoholism (NIAAA) R21 no. R21AA021223.

**CONFLICT OF INTEREST**

The authors declare no competing financial interests in relation to the work described.

[Supplementary information](#SD1){ref-type="supplementary-material"} is available at *Molecular Psychiatry*'s website

![Manhattan plot of alcohol drinker status in East-Asians **(a)** Before and **(b)** After conditioning for our top SNP *ALDH2* rs671.](nihms863512f1){#F1}

![Regional locus zoom plots for the alcohol consumption-associated loci in the trans-ethnic meta-analysis. Regional plots for the loci near **(a)** *GCKR*, and **(b)** *KLB* which reached genome-wide significance in the combined meta-analysis.](nihms863512f2){#F2}

###### 

Characteristics of the GERA subjects with alcohol consumption information by race/ethnicity group

  Characteristics            non-Hispanic whites   Hispanic/Latinos   East Asians    African Americans
  -------------------------- --------------------- ------------------ -------------- -------------------
  N (%)                      71 071 (82.0)         7 047 (8.1)        6 034 (7.0)    2 475 (2.9)
                                                                                     
  Male, n (%)                24 971 (35.1)         2 237 (31.7)       1 968 (32.6)   714 (28.9)
  Female, n (%)              46 100 (64.9)         4 810 (68.3)       4 066 (67.4)   1 761 (71.1)
                                                                                     
  Age at Survey (years)                                                              
   Mean ± SD                 62.3 ± 13.5           55.3 ± 14.9        55.3 ± 14.8    58.2 ± 14.0
                                                                                     
  Lean Body Mass (kg)                                                                
   Mean ± SD                 53.5 ± 10.2           51.6 ± 9.8         47.0 ± 8.6     53.9 ± 9.5
                                                                                     
  Nondrinker, n (%)          23 104 (32.5)         2 673 (37.9)       3 288 (54.5)   1 165 (47.1)
  Drinker, n (%)             47 967 (67.5)         4 374 (62.1)       2 746 (45.5)   1 310 (52.9)
   Alcohol Drinks per Week                                                           
   Mean ± SD                 7.3 ± 6.9             6.1 ± 6.4          4.9 ± 5.2      5.6 ± 6.2

Abbreviations: N, number; SD, standard deviation

###### 

Top genome-wide associations with alcohol consumption in each individual race/ethnicity group and in the trans-ethnic meta-analysis

  ----------- ---- ------------- ------------ --------- --- ---------- -------- --------------------------------------------------- -------------------------------------------- ------------------------------------------------------ ---------------------------------------------
                                                            NHW        0.28     1.05 (1.03--1.08)                                   6.74×10^−5^                                  0.04 (0.02--0.05)                                      1.05×10^−6^
                                                            H/L        0.38     0.97 (0.90--1.04)                                   0.41                                         0.05 (0.002--0.09)                                     0.04
  rs4665985   2    27,753,878    Intergenic   *GCKR*    C   EAS        0.44     1.02 (0.94--1.09)                                   0.68                                         0.02 (−0.04--0.08)                                     0.58
                                                            AA         0.12     1.05 (0.86--1.79)                                   0.63                                         0.21 (0.08--0.33)                                      0.002
                                                                                                                                                                                                                                        
                                                            **Meta**            1.04 (1.02--1.06)                                   5.0×10^−4^                                   0.04 (0.03--0.06)                                      **2.26×10^−8^**
                                                                                                                                                                                                                                        
                                                            NHW        0.47     0.96 (0.94--0.99)                                   0.0014                                       −0.03 (−0.05--−0.02)                                   8.95×10^−8^
                                                            H/L        0.48     0.92 (0.85--0.98)                                   0.01                                         −0.05 (−0.09--−0.01)                                   0.02
  rs7686419   4    39,406,370    Upstream     *KLB*     A   EAS        0.46     0.94 (0.87--1.02)                                   0.13                                         −0.10 (−0.15--−0.04)                                   7.67×10^−4^
                                                            AA         0.45     0.97 (0.85--1.73)                                   0.61                                         0.01 (−0.08--0.09)                                     0.91
                                                                                                                                                                                                                                        
                                                            **Meta**            0.96 (0.94--0.98)                                   4.08×10^−5^                                  −0.04 (−0.05--−0.02)                                   **3.41×10^−10^**
                                                                                                                                                                                                                                        
                                                            NHW        0.05     0.79 (0.74--0.84)                                   **2.47×10^−20^**                             −0.19 (−0.22--−0.16)                                   **1.91×10^−35^**
                                                            H/L        0.07     0.72 (0.59--0.85)                                   4.35×10^−7^                                  −0.21 (−0.30--−0.12)                                   2.58×10^−6^
  rs1229984   4    100,239,319   Missense     *ADH1B*   T   EAS        0.69     0.94 (0.86--1.02)                                   0.15                                         −0.07 (−0.12--−0.01)                                   0.02
                                                            AA         0.03     0.61 (0.26--0.69)                                   0.004                                        −0.11 (−0.39--0.16)                                    0.41
                                                                                                                                                                                                                                        
                                                            **Meta**            [\*](#TFN3){ref-type="table-fn"}0.79 (0.69--0.91)   [\*](#TFN3){ref-type="table-fn"}8.0×10^−4^   [\*](#TFN3){ref-type="table-fn"}−0.15 (−0.23--−0.07)   [\*](#TFN3){ref-type="table-fn"}3.04×10^−4^
                                                                                                                                                                                                                                        
                                                            NHW        0.0005   NA                                                  NA                                           NA                                                     NA
                                                            H/L        0.03     NA                                                  NA                                           NA                                                     NA
  rs671       12   112,241,766   Missense     *ALDH2*   A   EAS        0.21     0.40 (0.29--0.50)                                   **2.28×10^−72^**                             −0.17 (−0.26--−0.07)                                   5.42×10^−4^
                                                            AA         0.004    NA                                                  NA                                           NA                                                     NA
                                                                                                                                                                                                                                        
                                                            **Meta**            NA                                                  NA                                           NA                                                     NA
  ----------- ---- ------------- ------------ --------- --- ---------- -------- --------------------------------------------------- -------------------------------------------- ------------------------------------------------------ ---------------------------------------------

Abbreviations: Chr, chromosome; bp, base pair (based on UCSC Genome Browser Assembly February 2009 (GRCh37/hg19)); EA, Effect Allele; EAF, Effect Allele Frequency; NWW, non-Hispanic whites; H/L, Hispanic/Latinos; EAS, East Asians; AA, African Americans; Meta, combined trans-ethnic meta-analysis. The combined meta-analysis includes 71 071 non-Hispanic Whites, 7 047 Hispanic/Latinos, 6 034 East Asians, and 2 475 African Americans.

values for random effects model are reported when significant heterogeneity between race/ethnicity groups was detected (*I^2^*≥60%; Q≤0.05)

Bold numbers are p-values \<5.0×10^−8^; NA: *ALDH2* rs671 was not polymorphic (MAF\<0.5%) in non-Hispanic whites and African Americans, and was observed at a low frequency and imputation quality in Hispanic/Latinos, and so was excluded from the analysis in these race/ethnicity groups.

###### 

Results in our GERA cohort of SNPs previously associated with alcohol consumption and related phenotypes at genome-wide level significance (p\<5×10^−8^)

  ----------- ------------------- ------------ -------------------- ------------------------ ----------------------- --------- ------------------ -------------------- ------------------ -------------- ----------- ------------------- ------------------- ------
  1           173878471           rs1799876    *SERPINC1*           Xu *et al.* 2015         G                       0.33      0.99               0.43                 1.0                --             0.02        **0.0026**          **0.031**           --
  2           27741237            rs780094     *GCKR*               Schumann *et al.* 2016   T                       0.41      0.96               **0.0011**           **0.013**          0.52           −0.034      **2.38 × 10^−7^**   **2.86 × 10^−6^**   0.10
  3           20375546            rs11128951   *SGOL1*              Pan *et al.* 2013        G                       0.19      1.05               **0.0016**           **0.019**          --             0.003       0.75                1.0                 --
  4           39414993            rs11940694   *KLB*                Schumann *et al.* 2016   A                       0.42      0.95               **1.93×10^−4^**      **0.002**          0.17           −0.035      **1.37 × 10^−7^**   **1.64 × 10^−6^**   0.38
  7           50531885            rs11575537   *DDC*                Pan *et al.* 2013        T                       0.02      1.03               0.48                 1.0                --             0.03        0.33                1.0                 --
  7           69806023            rs6943555    *AUTS2*              Schumann *et al.* 2011   A                       0.25      1.02               0.095                1.0                --             0.03        **4.0×10^−4^**      **0.005**           --
                                                                                                                                                                                                                                                             
                                                                                             **East Asians**                                                                                                                                                 
                                                                                                                                                                                                                                                             
                                                                                                                                                  **Drinker Status**   **Drinks/Week**                                                                       
                                                                                                                                                                                                                                                             
  **Chr**     **Position (bp)**   **SNP**      **Gene**             **Previous Study**       **MA**                  **MAF**   **OR**             **P**                **P~adjusted~**    **P~condi~**   **Beta**    **P**               **P~adjusted~**     
                                                                                                                                                                                                                                                             
  12          111333622           rs10849915   *CCDC63*             Baik *et al.* 2011       C                       0.23      1.70               **4.21×10^−28^**     **3.37×10^−27^**   0.79           0.04        0.26                1.0                 
  111414461   rs12229654          *MYL2*       Baik *et al.* 2011   G                        0.18                    2.31      **1.75×10^−48^**   **1.40×10^−47^**     0.06               0.10           **0.041**   0.33                                    
  112645401   rs2074356           *C12orf51*   Baik *et al.* 2011   A                        0.14                    2.41      **5.48×10^−48^**   **4.38×10^−47^**     0.19               0.11           **0.045**   0.36                                    
  113409176   rs2072134           *OAS3*       Baik *et al.* 2011   A                        0.16                    1.58      **3.24×10^−16^**   **2.59×10^−15^**     0.34               0.06           0.22        1.0                                     
                                                                                                                                                                                                                                                             
                                                                                             **African-Americans**                                                                                                                                           
                                                                                                                                                  **Drinker Status**   **Drinks/Week**                                                                       
                                                                                                                                                                                                                                                             
  **Chr**     **Position (bp)**   **SNP**      **Gene**             **Previous Study**       **MA**                  **MAF**   **OR**             **P**                **P~adjusted~**                   **Beta**    **P**               **P~adjusted~**     
                                                                                                                                                                                                                                                             
  4           100190805           rs28864441   *LOC100507053*       Xu *et al.* 2015         T                       0.16      1.00               1.0                  1.0                               0.12        **0.027**           0.11                
  4           100229017           rs2066702    *ADH1B*              Xu *et al.* 2015         A                       0.17      1.00               0.97                 1.0                               0.12        **0.026**           0.10                
  ----------- ------------------- ------------ -------------------- ------------------------ ----------------------- --------- ------------------ -------------------- ------------------ -------------- ----------- ------------------- ------------------- ------

Abbreviations: Chr, chromosome; bp, base pair (based on UCSC Genome Browser Assembly February 2009 (GRCh37/hg19)); MA, Minor Allele; MAF, Minor Allele Frequency; Bold numbers are p-values \<0.05; P adjusted: p-values adjusted for Bonferroni correction (for 2 phenotypes and the number of SNPs tested for each ethnic group); P condi: p-values adjusted for *GCKR* rs4665985, *KLB* rs7686419, or *ALDH2* rs671
